Lighting the Flame Journal Club
A learning and connecting hematology experience led by alumni of the Lighting the Flame program.
The Lighting the Flame Journal Club is an online group that's open to all members of the Lighting the Flame community. Through a program of friendly and informal sessions, it aims to help:
- Foster collaboration
- Support professional growth
- Enhance engagement among Lighting the Flame participants and alumni
What a journal club event involves
Each monthly event focuses on a scientific article about a current topic in hematology.
Under the guidance of an expert mentor, you'll take part in a general discussion where you can analyze and learn more about a range of topics. These might include:
- Complex hematological concepts
- Diagnosis
- Sickness
- Treatments
Following this general discussion, you'll get an opportunity to join a breakout room that's tailored to your interests. Our three breakout rooms are the:
- Discussion room—where you can continue discussing the article with the mentor, presenter, and chair
- Career and hematology room—where you can exchange questions about hematology and career development with peers and experts
- Networking room—where you can reconnect with Lighting the Flame members and enjoy informal conversations
What you'll get if you join
The Lighting the Flame Journal Club offers an excellent opportunity for collaboration and growth for students, junior residents, and aspiring leaders in hematology.
Joining will help you to:
- Stay informed, and keep up with the latest developments in translational and clinical hematology
- Enhance your critical skills by learning how to analyze and interpret original scientific research
- Make career-enhancing connections by exchanging insights and ideas with fellow participants, alumni, and session mentors
How to join
To join our friendly club, and become part of a vibrant, global network of future leaders in hematology, just register on the Lighting the Flame page on EHA Campus.
Register for Lighting the Flame
Upcoming events
Our monthly virtual events will be held on the following dates.
All sessions will take place from 18:30–19:15 CET/CEST.
| Date | Topic | Article | Presenter | Chair | Mentor | Committee representative in charge |
|---|---|---|---|---|---|---|
| January 14, 2025 | Myeloid malignancies | Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1, Janssen M. et al., Blood (2022) | David Kegyes, Translational Medicine Department, MedFuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania |
Paschalis Evangelidis, Second Propedeutic, Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Greece |
Associate Prof Gabriel Ghiaur, The Johns Hopkins University, Baltimore, MD, USA |
Klaudia Zielonka |
| February 12, 2025 | Lymphoid malignancies | To be confirmed | Ibrahim Tsisman | Nawwar Maher | To be confirmed | Nawwar Maher |
| March 19, 2025 | New technologies in hematology | To be confirmed | To be confirmed | Jakub Czarny, Faculty of Medicine, Poznan University of Medical Sciences, Poland | To be confirmed | Anastasia Kosmidou |
| April 16, 2025 | Pediatric hematology | Myers RM, Devine K, Li Y, et al. Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia. Blood Adv. (2024) | Jakub Czarny, Faculty of Medicine, Poznan University of Medical Sciences, Poland |
Anastasia Kosmidou, Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Oxford University, UK |
Prof Krzysztof Kałwak Department of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Wroclaw Medical University, Poland |
Anastasia Kosmidou |
| May 14, 2025 | HSCT | Horwitz ME, et al., Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study. Blood. (2021) |
Alexandru Caragata, Department of Molecular Medicine, University of Pavia, Italy |
David Kegyes, Translational Medicine Department, MedFuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania |
Prof. Luca Arcaini, Head of Hematology Division, Policlinico San Matteo Foundation, and Full Professor of Hematology, Department of Molecular Medicine, University of Pavia, Italy |
Nawwar Maher |
| June 19, 2025 | Lymphoid malignancies | To be confirmed | Salma Ismail | Klaudia Zielonka, Dep. of Hematology, Transplantation, and Internal Medicine, Medical University of Warsaw, Poland |
To be confirmed | To be confirmed |
Back